000			01454 a2200409 4500
005			20250513233330.0
264		0	_c20010329
008			200103s 0 0 eng d
022			_a0003-2409
024	7		_a10.1046/j.1365-2044.2001.01717.x _2doi
040			_aNLM _beng _cNLM
100	1		_aKleinsasser, A
245	0	0	_aReversing sevoflurane-associated Q-Tc prolongation by changing to propofol. _h[electronic resource]
260			_bAnaesthesia _cMar 2001
300			_a248-50 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAnesthesia, General _xadverse effects
650	0	4	_aAnesthetics, Inhalation _xadverse effects
650	0	4	_aAnesthetics, Intravenous _xtherapeutic use
650	0	4	_aElectrocardiography _xdrug effects
650	0	4	_aFemale
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aIntraoperative Complications _xchemically induced
650	0	4	_aLong QT Syndrome _xchemically induced
650	0	4	_aMethyl Ethers _xadverse effects
650	0	4	_aPropofol _xtherapeutic use
650	0	4	_aSevoflurane
700	1		_aLoeckinger, A
700	1		_aLindner, K H
700	1		_aKeller, C
700	1		_aBoehler, M
700	1		_aPuehringer, F
773	0		_tAnaesthesia _gvol. 56 _gno. 3 _gp. 248-50
856	4	0	_uhttps://doi.org/10.1046/j.1365-2044.2001.01717.x _zAvailable from publisher's website
999			_c11188199 _d11188199